| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,286,692 |
| 52
Week Range: |
$0.92 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Riga Thomas J |
EVP, COO & CCO |
• – – |
2021-02-19 |
4 |
AS |
$3.64 |
$18,250 |
D/D |
(5,018) |
459,650 |
|
2% |
|
| Lebel Francois |
Chief Medical Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
110,309 |
418,526 |
|
- |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
110,309 |
354,807 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
119,579 |
445,806 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
278,090 |
648,119 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
134,410 |
464,668 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2021-02-17 |
4 |
A |
$3.61 |
$36,100 |
D/D |
10,000 |
125,967 |
|
- |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2021-02-10 |
4 |
AS |
$3.93 |
$9,825 |
D/D |
(2,500) |
244,498 |
|
2% |
|
| Mcgahan Keith M |
Chief Legal Officer |
• – – |
2021-02-09 |
4 |
AS |
$3.93 |
$7,770 |
D/D |
(1,977) |
246,998 |
|
7% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2021-01-20 |
4 |
AS |
$4.31 |
$43,100 |
D/D |
(10,000) |
330,258 |
|
-10% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2021-01-20 |
4 |
AS |
$4.31 |
$16,762 |
D/D |
(3,889) |
370,029 |
|
-10% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2021-01-20 |
4 |
AS |
$4.31 |
$8,379 |
D/D |
(1,944) |
330,608 |
|
-10% |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2021-01-19 |
4 |
AS |
$3.81 |
$302,894 |
D/D |
(76,283) |
340,258 |
|
-13% |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2021-01-19 |
4 |
AS |
$3.81 |
$14,638 |
D/D |
(3,844) |
373,918 |
|
-13% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2021-01-19 |
4 |
AS |
$3.81 |
$9,832 |
D/D |
(2,582) |
332,552 |
|
-13% |
|
| Vacirca Jeff L |
Director |
– • – |
2020-12-24 |
4 |
A |
$3.79 |
$37,900 |
D/D |
10,000 |
115,967 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-12-16 |
4 |
AS |
$4.70 |
$709,225 |
D/D |
(150,899) |
377,762 |
|
-34% |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2020-12-14 |
4 |
AS |
$5.00 |
$128,480 |
D/D |
(25,696) |
335,134 |
|
-40% |
|
| Brennan Nora |
Director |
– • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2020-11-18 |
4 |
AS |
$4.13 |
$671,013 |
D/D |
(162,473) |
528,661 |
|
-20% |
|
| Vacirca Jeff L |
Director |
– • – |
2020-11-09 |
4 |
A |
$3.78 |
$37,800 |
D/D |
10,000 |
105,967 |
|
- |
|
| Lebel Francois |
Chief Medical Officer |
• – – |
2020-11-09 |
4 |
AS |
$3.56 |
$17,800 |
D/D |
(5,000) |
306,424 |
|
-9% |
|
| Lebel Francois |
Chief Medical Officer |
• – – |
2020-11-06 |
4 |
AS |
$3.50 |
$24,609 |
D/D |
(7,025) |
301,424 |
|
1% |
|
| Vacirca Jeff L |
Director |
– • – |
2020-09-16 |
4 |
A |
$4.24 |
$4,238 |
D/D |
1,000 |
95,967 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2020-08-28 |
4 |
A |
$4.08 |
$81,600 |
D/D |
20,000 |
94,967 |
|
- |
|
658 Records found
|
|
Page 5 of 27 |
|
|
